计算溶液所需的质量、体积或浓度。
提供 ≥97% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存,干燥。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Galegine hydrochloride, a guanidine derivative, contributes to weight loss in mice. Guanidine hydrochloride is the compound derived from G. officinalis , which gave rise to the biguanides, metformin and phenformin. Galegine hydrochloride activates AMPK in 3T3-L1 adipocytes and L6 myotubes, as well as in the H4IIE rat hepatoma and HEK293 human kidney cell lines. Galegine hydrochloride has antibacterial activity, with minimum inhibitory concentration of 4 mg/L against Staphylococcus aureus strains.
In Vitro
Pre-treatment with Galegine hydrochloride (10 μM-3 mM; 5 h) produces a concentration-dependent stimulation of insulin-independent glucose uptake by 3T3-L1 adipocytes without any effect on cell viability. Incubation with Galegine hydrochloride (1 μM-1 mM, 5 h) produces a concentration-dependent stimulation of glucose uptake into L6 myotubes, again without any effect on cell viability. Galegine hydrochloride (0.3-300 μM; 24 hours) produced a slight reduction in basal glycerol release and a more marked reduction in isoprenaline-stimulated glycerol release from 3T3-L1 adipocytes. Incubation of H4IIE rat hepatoma cells with Galegine hydrochloride (10 or 300 μM) for up to 6 hours produces a time-dependent activation of AMPK measured in cell lysates, with maximal activation at 360 min and twofold activation still evident at 24 hous in the presence of 300 μM Galegine hydrochloride. The effect of 300 ΜM Galegine hydrochloride is markedly greater than that of 10 μM. Incubation with Galegine hydrochloride for 1 hour produces a concentration-dependent activation of AMPK in both 3T3L-1 adipocytes and L-6 myotubes. Galegine hydrochloride also produces a concentration-dependent activation of the enzyme in a human kidney cell line (HEK293). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Galegine hydrochloride (63 mg/kg; feed; daily for 11 days) produces a significant reduction in body weight . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Adult male BALB/c mice Dosage: 63 mg/kg Administration: feed; daily for 11 days Result: Produced a significant reduction in body weight.
Form:Solid
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机氮化合物 |
| 类(Class) | 有机氮化合物 |
| 亚类(Subclass) | 胍类 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 胍类 |
| 其他上位类(Alternative Parents) | 炔丙基型1,3-偶极有机化合物 甲脒类 有机光子化合物 盐酸盐 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 脂肪族无环化合物 |
| 取代基(Substituents) | 脂肪族非环化合物 - 羧酰亚胺 - 胍 - 烃衍生物 - 氟氯烃 - 有机1,3-双极性化合物 - 有机氮化合物 - 丙炔型1,3-双极性有机化合物 |
| 描述(Description) | 该化合物属于有机化合物中的胍类化合物。这类化合物含有胍基结构单元,其通式为(R1R2N)(R3R4N)C=N-R5。 |
| 外部描述符(External Descriptors) | 暂无 |